Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnoud H de Ru

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2017
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytesYvonne M C Kooy-Winkelaar, Dagmar Bouwer, George M C Janssen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.
Plos One|June 25, 2015
Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97Hanneke Hoelen, Arnaud Zaldumbide, Wouter F van Leeuwen, et al.
ACS Chemical Biology|August 29, 2023
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2Jin Gan, Jelle de Vries, Jimmy J L L Akkermans, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2023
CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimicMaarten van Dinther, Kyle T Cunningham, Shashi Prakash Singh, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinomaRosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, et al.
Blood|June 2, 2011
MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in miceAnnemarie Meenhuis, Peter A van Veelen, Hans de Looper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transferAvital L Amir, Dirk M van der Steen, Marleen M van Loenen, et al.
Molecular Therapy Oncolytics|January 2, 2023
A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
Journal of Hematology & Oncology|February 28, 2023
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chainMiranda H Meeuwsen, Anne K Wouters, Tassilo L A Wachsmann, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2017
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytesYvonne M C Kooy-Winkelaar, Dagmar Bouwer, George M C Janssen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.
Plos One|June 25, 2015
Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97Hanneke Hoelen, Arnaud Zaldumbide, Wouter F van Leeuwen, et al.
ACS Chemical Biology|August 29, 2023
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2Jin Gan, Jelle de Vries, Jimmy J L L Akkermans, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2023
CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimicMaarten van Dinther, Kyle T Cunningham, Shashi Prakash Singh, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinomaRosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, et al.
Blood|June 2, 2011
MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in miceAnnemarie Meenhuis, Peter A van Veelen, Hans de Looper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transferAvital L Amir, Dirk M van der Steen, Marleen M van Loenen, et al.
Molecular Therapy Oncolytics|January 2, 2023
A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
Journal of Hematology & Oncology|February 28, 2023
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chainMiranda H Meeuwsen, Anne K Wouters, Tassilo L A Wachsmann, et al.
Pageof 10